{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:10:52Z","timestamp":1782519052648,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2015R1A5A2008833"],"award-info":[{"award-number":["NRF-2015R1A5A2008833"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11239-020-02103-w","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T07:02:36Z","timestamp":1586588556000},"page":"969-981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Impact of platelet\u2013fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease"],"prefix":"10.1007","volume":"50","author":[{"given":"Jae Seok","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hwa","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Yoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Gyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwhi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Jae","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choong Hwan","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0403-3726","authenticated-orcid":false,"given":"Young-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,11]]},"reference":[{"key":"2103_CR1","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","volume":"297","author":"PG Steg","year":"2007","unstructured":"Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, R\u00f6ther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S, Registry Investigators REACH (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297:1197\u20131206","journal-title":"JAMA"},{"key":"2103_CR2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jama.2010.1322","volume":"304","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, Wilson PW, Alberts MJ, D'Agostino R, Liau CS, Mas JL, R\u00f6ther J, Smith SC Jr, Salette G, Contant CF, Massaro JM, Steg PG, Registry Investigators REACH (2010) Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 304:1350\u20131357","journal-title":"JAMA"},{"key":"2103_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIR.0b013e31820d8d78","volume":"124","author":"TG Brott","year":"2011","unstructured":"Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ (2011) ASA\/ACCF\/AHA\/AANN\/AANS\/ACR\/ ASNR\/CNS\/SAIP\/SCAI\/SIR\/SNIS\/SVM\/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. Circulation 124:489\u2013532","journal-title":"Circulation"},{"key":"2103_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jcin.2013.08.008","volume":"6","author":"JY Lee","year":"2013","unstructured":"Lee JY, Lee SW, Lee WS, Han S, Park YK, Kwon CH, Jang JY, Cho YR, Park GM, Ahn JM, Kim WJ, Park DW, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ (2013) Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease. JACC Cardiovasc Interv 6:1303\u20131313","journal-title":"JACC Cardiovasc Interv"},{"key":"2103_CR5","first-page":"e726","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) 2016 AHA\/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135:e726\u2013779","journal-title":"Circulation"},{"issue":"2 Suppl","key":"2103_CR6","doi-asserted-by":"publisher","first-page":"e669S","DOI":"10.1378\/chest.11-2307","volume":"141","author":"P Alonso-Coello","year":"2012","unstructured":"Alonso-Coello P, Bellmunt S, McGorrian C, Anand SS, Guzman R, Criqui MH, Akl EA, Vandvik PO, Lansberg MG, Guyatt GH, Spencer FA (2012) Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e669S\u2013690S","journal-title":"Chest"},{"key":"2103_CR7","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"ES Organisation","year":"2011","unstructured":"Organisation ES, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Cl\u00e9ment D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, R\u00f6ther J, Sievert H, van Sambeek M, Zeller T (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32:2851\u20132906","journal-title":"Eur Heart J"},{"key":"2103_CR8","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.jacc.2013.03.036","volume":"61","author":"S Spiliopoulos","year":"2013","unstructured":"Spiliopoulos S, Pastromas G, Katsanos K, Kitrou P, Karnabatidis D, Siablis D (2013) Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cut-off value of on-treatment high platelet reactivity. J Am Coll Cardiol 61:2428\u20132434","journal-title":"J Am Coll Cardiol"},{"key":"2103_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1611688","volume":"376","author":"WR Hiatt","year":"2017","unstructured":"Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Milleg\u00e5rd M, Reist C, Patel MR, EUCLID Trial Steering Committee Investigators (2017) Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med 376:32\u201340","journal-title":"N Engl J Med"},{"key":"2103_CR10","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","volume":"127","author":"MP Bonaca","year":"2013","unstructured":"Bonaca MP, Scirica BM, Creager MA, Olin J, Bounameaux H, Dellborg M, Lamp JM, Murphy SA, Braunwald E, Morrow DA (2013) Vorapaxar in patients with peripheral artery disease: results from TRA2\u00baP-TIMI 50. Circulation 127:1522\u20131529","journal-title":"Circulation"},{"key":"2103_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","volume":"391","author":"SS Anand","year":"2018","unstructured":"Anand SS, Bosch J, Eikelboom JW, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, St\u00f6rk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S, Investigators COMPASS (2018) Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 391:219\u2013229","journal-title":"Lancet"},{"key":"2103_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2015.01.021","volume":"239","author":"P Rein","year":"2015","unstructured":"Rein P, Saely CH, Silbernagel G, Mathies R, Drexel H, Baumgartner I (2015) Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease. Atherosclerosis 239:299\u2013303","journal-title":"Atherosclerosis"},{"key":"2103_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, CANTOS Trial Group (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:1119\u20131131","journal-title":"N Engl J Med"},{"key":"2103_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1160\/TH13-08-0643","volume":"111","author":"YH Jeong","year":"2017","unstructured":"Jeong YH, Bliden KP, Shuldiner AR, Tantry US, Gurbel PA (2017) Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes. Thromb Haemost 111:713\u2013724","journal-title":"Thromb Haemost"},{"key":"2103_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jacc.2005.04.051","volume":"46","author":"A Khera","year":"2005","unstructured":"Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH Jr, Grundy SM, de Lemos JA (2005) Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46:464\u2013469","journal-title":"J Am Coll Cardiol"},{"key":"2103_CR16","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, RaoSV BDL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123:2736\u20132747","journal-title":"Circulation"},{"key":"2103_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Executive Group on behalf of the Joint ESC\/ACC\/AHA\/WHF Task Force for the Universal Definition of Myocardial Infarction (2018) Fourth universal definition of myocardial infarction. J Am Coll Cardiol 72:2231\u20132264","journal-title":"J Am Coll Cardiol"},{"key":"2103_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/1358863X16673730","volume":"21","author":"AT Hirsch","year":"2016","unstructured":"Hirsch AT, Van\u2019t Hof JR, Bonaca M (2016) The conundrum of ALI and systemic embolic events: seeing our way to improved vascular health. Vasc Med 21:535\u2013538","journal-title":"Vasc Med"},{"key":"2103_CR19","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","volume":"116","author":"MH Criqui","year":"2015","unstructured":"Criqui MH, Aboyans V (2015) Epidemiology of peripheral artery disease. Circ Res 116:1509\u20131526","journal-title":"Circ Res"},{"key":"2103_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jacc.2017.11.021","volume":"71","author":"WS Jones","year":"2018","unstructured":"Jones WS, Patel MR (2018) Antithrombotic therapy in peripheral artery disease: generating and translating evidence into practice. J Am Coll Cardiol 71:352\u2013362","journal-title":"J Am Coll Cardiol"},{"key":"2103_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jvs.2007.05.039","volume":"46","author":"S Rajagopalan","year":"2007","unstructured":"Rajagopalan S, McKay I, Ford I, Bachoo P, Greaves M, Brittenden J (2007) Platelet activation increases with the severity of peripheral artery disease: implications for clinical management. J Vasc Surg 46:485\u2013490","journal-title":"J Vasc Surg"},{"key":"2103_CR22","doi-asserted-by":"publisher","first-page":"4543065","DOI":"10.1155\/2018\/4543065","volume":"2018","author":"BT Maatman","year":"2018","unstructured":"Maatman BT, Schmeisser G, Kreutz RP (2018) Fibrin clot strength in patients with diabetes mellitus measured by thrombelastography. J Diabetes Res 2018:4543065","journal-title":"J Diabetes Res"},{"key":"2103_CR23","first-page":"3709534","volume":"2018","author":"QF Chen","year":"2018","unstructured":"Chen QF, Cao D, Ye TT, Deng HH, Zhu H (2018) Peripheral arterial disease in type 2 diabetes is associated with an increase in fibrinogen levels. Int J Endocrinol 2018:3709534","journal-title":"Int J Endocrinol"},{"key":"2103_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/0003319717739720","volume":"69","author":"P Altes","year":"2018","unstructured":"Altes P, Perez P, Esteban C, S\u00e1nchez Mu\u00f1oz-Torrero JF, Aguilar E, Garc\u00eda-D\u00edaz AM, \u00c1lvarez LR, Jim\u00e9nez PE, Sahuquillo JC, Monreal M, FRENA Investigators (2018) Raised fibrinogen levels and outcome in outpatients with peripheral artery disease. Angiology 69:507\u2013512","journal-title":"Angiology"},{"key":"2103_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.atherosclerosis.2010.12.040","volume":"215","author":"A Undas","year":"2011","unstructured":"Undas A, Nowakowski T, Cie\u015bla-Dul M, Sadowski J (2011) Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans. Atherosclerosis 215:481\u2013486","journal-title":"Atherosclerosis"},{"key":"2103_CR26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/eurheartj\/ehy013","volume":"39","author":"W Sumaya","year":"2018","unstructured":"Sumaya W, Wallentin L, James SK, Siegbahn A, Gabrysch K, Bertilsson M, Himmelmann A, Ajjan RA, Storey RF (2018) Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. Eur Heart J 39:1078\u20131085","journal-title":"Eur Heart J"},{"key":"2103_CR27","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/CIRCULATIONAHA.114.011021","volume":"130","author":"S Subherwal","year":"2014","unstructured":"Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM (2014) Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database. Circulation 130:1812\u20131819","journal-title":"Circulation"},{"key":"2103_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa065959","volume":"357","author":"WAVET Investigators","year":"2007","unstructured":"Investigators WAVET, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G (2007) Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357:217\u2013227","journal-title":"N Engl J Med"},{"key":"2103_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ijcard.2014.07.084","volume":"176","author":"S Solbeck","year":"2014","unstructured":"Solbeck S, Meyer MA, Johansson PI, Meyer AS, Cotton BA, Stensballe J, Sch\u00f6tt U, Ostrowski SR (2014) Monitoring of dabigatran anticoagulation and its reversal in vitro by thromboelastography. Int J Cardiol 176:794\u2013796","journal-title":"Int J Cardiol"},{"key":"2103_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2017.11.001","volume":"39","author":"AS Antonopoulos","year":"2018","unstructured":"Antonopoulos AS, Papanikolaou E, Vogiatzi G, Oikonomou E, Tousoulis D (2018) Anti-inflammatory agents in peripheral arterial disease. Curr Opin Pharmacol 39:1\u20138","journal-title":"Curr Opin Pharmacol"},{"key":"2103_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jvs.2010.02.004","volume":"52","author":"MH Criqui","year":"2010","unstructured":"Criqui MH, Ho LA, Denenberg JO, Ridker PM, Wassel CL, McDermott MM (2010) Biomarkers in peripheral arterial disease patients and near- and longer-term mortality. J Vasc Surg 52:85\u201390","journal-title":"J Vasc Surg"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02103-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T23:36:51Z","timestamp":1618097811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02103-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,11]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02103-w","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,11]]},"assertion":[{"value":"11 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Jeong has received honoraria for lectures from AstraZeneca, Sanofi-Aventis, Daiichi Sankyo\/Lilly, Haemonetics, Otsuka, Han-mi Pharmaceuticals and Yuhan Pharmaceuticals; and research grants or support from AstraZeneca, Korean Society of Interventional Cardiology, Han-mi Pharmaceuticals, Yuhan Pharmaceuticals, Otsuka and Haemonetics. Dr Gurbel reports serving as a consultant fees\/receiving honoraria from Daiichi Sankyo, Bayer, AstraZeneca, Merck, Boehringer, New Haven Pharmaceuticals, Janssen, and CSL and receiving grants from the National Institutes of Health, Daiichi Sankyo, CSL, AstraZeneca, Harvard Clinical Research Institute, Haemonetics, New Haven Pharmaceuticals, Duke Clinical Research Institute, Sinnowa, and Coramed. Dr Gurbel has patents in the field of platelet function testing. The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}